Skip to main content
NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDHKD0.00%NZDJPY0.00%CADJPY0.00%USDDKK0.00%USDZAR0.00%USDPLN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.33%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.58%ZECUSDT+0.91%DOGEUSD+20.76%XMRUSDT-2.29%LINKUSD+23.15%BCHUSDT+0.92%XLMUSD-1.45%UNIUSD+1.67%LTCUSD+17.32%SUIUSD-1.32%HBARUSDT-0.40%TONUSD+36.45%TAOUSDT+1.28%AAVEUSD+0.02%DOTUSDT-1.15%ICPUSDT-0.80%ONDOUSDT-0.47%WLDUSDT-2.67%ARBUSDT+0.48%JUPUSDT-1.94%INJUSDT+3.64%ATOMUSDT+0.29%STXUSDT+0.23%TIAUSDT-0.37%PYTHUSDT+4.78%FETUSDT-1.86%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.78%OPUSDT-1.73%IOTAUSDT-1.49%WIFUSDT-3.57%POLUSDT-0.04%AXSUSDT-1.70%EOSUSDT-2.79%FARTCOINUSDT-2.25%DYDXUSDT-2.69%GALAUSDT-2.36%ORDIUSDT-1.20%RONINUSDT-1.68%NOTUSDT0.00%NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDHKD0.00%NZDJPY0.00%CADJPY0.00%USDDKK0.00%USDZAR0.00%USDPLN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.33%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.58%ZECUSDT+0.91%DOGEUSD+20.76%XMRUSDT-2.29%LINKUSD+23.15%BCHUSDT+0.92%XLMUSD-1.45%UNIUSD+1.67%LTCUSD+17.32%SUIUSD-1.32%HBARUSDT-0.40%TONUSD+36.45%TAOUSDT+1.28%AAVEUSD+0.02%DOTUSDT-1.15%ICPUSDT-0.80%ONDOUSDT-0.47%WLDUSDT-2.67%ARBUSDT+0.48%JUPUSDT-1.94%INJUSDT+3.64%ATOMUSDT+0.29%STXUSDT+0.23%TIAUSDT-0.37%PYTHUSDT+4.78%FETUSDT-1.86%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.78%OPUSDT-1.73%IOTAUSDT-1.49%WIFUSDT-3.57%POLUSDT-0.04%AXSUSDT-1.70%EOSUSDT-2.79%FARTCOINUSDT-2.25%DYDXUSDT-2.69%GALAUSDT-2.36%ORDIUSDT-1.20%RONINUSDT-1.68%NOTUSDT0.00%
NO

Novavax, Inc. (NVAX)

NASDAQ • Healthcare

$9.69
-$0.29 (-2.9%)
Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$9.84
Day Range$9.62 - $9.93
Avg. Volume (3M)8.9M
Market Cap$1.5B
52 Week Range
$6.2$13.39
Next EarningsIn 11 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$56.6M100%
Gross Profitminus cost of goods$42.4M75%

In plain terms: out of every $100 in revenue, Novavax, Inc. currently loses $94.

Fundamentals & Financials

Revenue (TTM)
$413.7M
Net Income (TTM)
-$247.7M
EPS (TTM)
-$1.52
ROA (TTM)
-25.92%
Current Ratio
2.33

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+116.7%Q1 2026$0.11
+76.0%Q2 2026-$0.06
+15.8%Q3 2026-$0.32
Next

Nov 5

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Novavax, Inc. (NVAX) reports on November 5, 2026. Wall Street is looking for EPS of -$0.232 on revenue of $72.7 million. For trailing context, revenue fell -76.3% year over year last quarter. NVAX has beaten EPS in 7 of 8 most recent quarters, making upside/downside versus consensus a key focus.

View full earnings history

About Novavax, Inc.

Novavax, Inc. develops and commercializes vaccines within the biotechnology sector, centered on preventing serious infectious diseases. The company trades on the NASDAQ Global Select Market under NVAX and generated $1.1 billion of revenue in FY2025, with its work spanning marketed and developing vaccine programs for several respiratory viruses.

Name
Novavax, Inc.
CEO
John Charles Jacobs
Industry
Healthcare
Year Founded
1987
Employees
749

Today's Snapshot

AI-generated

NVAX closed 2.9% below yesterday's close, in line with a weaker sector. Shares changed hands at about half of its usual level.

Trading Volume

Below 10d avg (7.8M)

4.4M

vs S&P 500 Today

Underperforming Market

-2.38%

Updated: October 23, 2026 at 20:27 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
NVAX is showing a bearish technical profile driven by firm directional strength and weakening momentum, with the ADX signaling a clear trend while momentum measures such as CCI are negative and RSI sits below neutral. The stock is trading under most short- and medium-term moving averages while roughly near the long-term averages, and on-balance volume is declining, which supports the downside bias. Volatility is elevated for the stock, reflecting larger percentage moves, and the classic pivot sits above the current price, offering a nearby resistance reference. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$9.21 - $11.08
    Sell
  • RSI (14)40.33
    Neutral
  • Stochastic %K (14, 3, 3)12.80
    Buy
  • MACD Level (12, 26)0.10
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.